EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine Pancreatic Ductal Adenocarcinoma

Guo-Chao Zhao, Ning Pu, Abulimiti Nuerxiati, Han-Lin Yin, Lei Zhang, Wen-Hui Lou, Wen-Chuan Wu

Cancer Screening and Prevention · 2022

DOI: 10.14218/csp.2022.00001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Screening and Prevention, 2022. Verfasst von Guo-Chao Zhao und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhao, G., Pu, N., Nuerxiati, A., Yin, H., Zhang, L., Lou, W., & Wu, W. (2022). Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine Pancreatic Ductal Adenocarcinoma. Cancer Screening and Prevention. https://doi.org/10.14218/csp.2022.00001

Vancouver

Zhao G, Pu N, Nuerxiati A, Yin H, Zhang L, Lou W, et al. Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine Pancreatic Ductal Adenocarcinoma. Cancer Screening and Prevention. 2022. doi:10.14218/csp.2022.00001

BibTeX
@article{Zhao2022,
  author = {Zhao, Guo-Chao and Pu, Ning and Nuerxiati, Abulimiti and Yin, Han-Lin and Zhang, Lei and Lou, Wen-Hui and Wu, Wen-Chuan},
  title = {Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine Pancreatic Ductal Adenocarcinoma},
  journal = {Cancer Screening and Prevention},
  year = {2022},
  doi = {10.14218/csp.2022.00001}
}
Kostenlos starten →